Sellers in European M&A deals took on less risk in 2014 as the region saw a major uplift in M&A deal value, according to a study by CMS Cameron McKenna
The UK Financial Conduct Authority's (FCA) review of structured product governance has criticised the ways in which the instruments are developed and sold, warning that binding rules may be necessary.
Opposition to white lists is growing as the rise of cov-lite deals exposes investors further to the practice. But the feature is expected to linger until deal volumes start outweighing demand
The regulator's review of structured product governance has criticised the ways in which the instruments are developed and sold. But blame may not lie squarely with the industry
